Gayle Barbara Duncan
Affiliations
- at Ovid Therapeutics Inc. (OVID), 2025-06-18
- at Halozyme Therapeutics Inc. (HALO), 2025-05-02
- at Atea Pharmaceuticals Inc. (AVIR), 2024-06-21
- at Fusion Pharmaceuticals Inc. (FUSN), 2024-06-04
- Director at Jounce Therapeutics Inc. (JNCE), 2023-05-04
- Director at Adaptimmune Therapeutics Plc (ADAP), 2022-07-01
- Director at Immunomedics Inc (IMMU), 2020-10-23
- Director at Aevi Genomic Medicine Inc. (GNMX), 2020-02-05
- Director at Innoviva Inc. (INVA), 2017-04-24
- Chief Accounting Officer at Intercept Pharmaceuticals Inc (ICPT), 2016-10-06
Insider Trading: Purchases See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| GNMX | $1.26 | 59,524 | $75,000.24 | 59,524 | 2017-10-17 | Filing |
Insider Trading: Sales See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| JNCE | $10.50 | 5,000 | $52,500.00 | 0 | 2020-09-15 | Filing |
| JNCE | $9.50 | 5,000 | $47,500.00 | 5,000 | 2020-09-15 | Filing |
| JNCE | $28.11 | 2,000 | $56,220.00 | 0 | 2018-03-15 | Filing |
| JNCE | $25.00 | 4,000 | $100,000.00 | 0 | 2018-01-26 | Filing |
| ICPT | $163.20 | 147 | $23,990.36 | 30,661 | 2016-10-03 | Filing |